Smartphone app to help manage side effects in people having cancer treatment
Tests a phone app sharing daily symptom reports with care teams during cancer treatment.
Key facts
- Who runs it
- Barbara Ann Karmanos Cancer Institute
- Where
- Detroit, United StatesSee the site
- Trial code
- Registry title
- MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- Nov 2026
- Expected to end
- 30 Nov 2028
- Type of study
- Interventional
- Treatments tested
- MyPatientPal+
- Record updated
- 10 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with breast, gastrointestinal, lung, prostate, head and neck, or bladder cancer who are about to start chemotherapy. They will use a smartphone app to report daily side effects.
- Age
- 18 to 70 years
- Sex
- All sexes can join.
- Disease stage
- Breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer. No stage is named.
- Earlier treatment
- About to start chemotherapy with one of the regimens listed in the protocol.
Main reasons for not taking part
- Cognitive or perceptual problems that prevent completing the study measures
- Cannot speak, read and write English
- No stable internet connection
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Patients-
- 18-70 Years of age
- have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer
- about to initiate chemotherapy using one of the regimens listed in the protocol
- be able to speak, read, and write English
- willing and able to provide consent
- have access to a stable internet connection; Providers:
- being a practicing oncologist
- treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app
- provide consent for the study
Who cannot take part
- Patients-
- cognitive or perceptual disturbances that prevent completing study measures Provider-
- None
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in United States
- Karmanos Cancer InstituteDetroit, United StatesContact: Lead Clinical Research AssociateNo longer taking part
About the trial
What the trial wants to find out
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects
The group in the trial
- MyPatientPal+ Smartphone ApplicationTreatment being tested
Participants report daily side effects and medications. Application includes a provider dashboard to track patients side effects and medications.
Treatment: MyPatientPal+
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
- Plain-language title
- Smartphone app to help manage side effects in people having cancer treatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07928154, who can take part
- Record updated
- 10 November 2026